Showing results (21-30 of 95) with videos related to
Sort By:
Pageof 10
Gynecologic Oncology|March 31, 2000
Phase II evaluation of 24-h continuous infusion topotecan in recurrent, potentially platinum-sensitive ovarian cancer: A Gynecologic Oncology Group studyM Markman, J A Blessing, R D Alvarez, et al.Gynecologic Oncology|April 1, 1990
Early invasive cervical cancer with pelvic lymph node involvement: to complete or not to complete radical hysterectomy?M E Potter, R D Alvarez, H M Shingleton, et al.Gynecologic Oncology|October 1, 1995
A decision analysis of practice patterns used in evaluating and treating abnormal Pap smearsP Y Roland, R W Naumann, R D Alvarez, et al.Gynecologic Oncology|September 1, 1993
The Groshong catheter as an intraperitoneal access device in the treatment of ovarian cancer patientsR W Naumann, R D Alvarez, E E Partridge, et al.Southern Medical Journal|November 1, 1993
Staging ovarian cancer diagnosed during laparoscopy: accuracy rather than immediacyR D Alvarez, L C Kilgore, E E Partridge, et al.Cancer Gene Therapy|March 1, 1996
Intracellular antibody against erbB-2 mediates targeted tumor cell eradication by apoptosisJ Deshane, J Grim, S Loechel, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Novel gene therapy strategy to accomplish growth factor modulation induces enhanced tumor cell chemosensitivityM N Barnes, J S Deshane, G P Siegal, et al.Journal of Molecular Medicine (Berlin, Germany)|June 13, 1998
The level of erbB2 expression predicts sensitivity to the cytotoxic effects of an intracellular anti-erbB2 sFvJ Grim, J Deshane, G P Siegal, et al.Cancer Gene Therapy|October 7, 2000
Antineoplastic effect of anti-erbB-2 intrabody is not correlated with scFv affinity for its targetW Arafat, J Gómez-Navarro, J Xiang, et al.Obstetrics and Gynecology|January 1, 1997
Gene therapy and ovarian cancer: a reviewM N Barnes, J S Deshane, M Rosenfeld, et al.Pageof 10